Navigation Links
CitiusTech Completes Another Milestone Year: Revenues Grow by 59% in 2011

PRINCETON, New Jersey, February 15, 2012 /PRNewswire/ --

CitiusTech, a leading healthcare technology solution provider, announced that it has completed the calendar year 2011 with 59% growth in revenues. 2011 is now the fifth consecutive year that CitiusTech has recorded over 50% Y-o-Y revenue growth. In 2011, CitiusTech won the Red Herring Award for leadership in healthcare technology. CitiusTech was selected as a finalist at the 2011 American Business Awards for being one of the fastest growing technology companies in the United States.

Growth in 2011 has been driven by existing customer relationships (93% customer retention) and by new customer additions across North America and Europe.  CitiusTech also enhanced its capabilities across its key service offerings - software product engineering, professional services and healthcare BI/analytics. CitiusTech's BI-Clinical platform became the only modular BI solution to be ONC-ATCB 2011/2012 certified for all Eligible Hospital (EH) and Eligible Professional (EP) Meaningful Use Clinical Quality Measures. BI-Clinical was also one of the first BI/analytics platforms to comply with all 33 ACO quality measures that were released by CMS.

During 2011, CitiusTech's software engineering practice enabled many leading healthcare IT vendors to enhance and architect their solutions (e.g., for mobile and cloud computing) and comply with new technology and regulatory needs (including Meaningful Use, ACO etc.). In addition, CitiusTech professional services team formed strategic partnerships with HIE, EMR and clinical application organizations to help them scale their professional services organizations worldwide. With over 250 HL7 certified professionals, CitiusTech retains the distinction of having the largest number of certified interoperability professionals worldwide. CitiusTech also expanded its reach, with new offices in Princeton NJ, Singapore and India.

"2011 has been an excellent year for CitiusTech. Our ability to form and grow long-term partnerships with healthcare technology organizations and support their business growth has been key to our success," said Rizwan Koita, CEO, CitiusTech. "Our BI-Clinical platform has been strongly received by our partners for population health management, care coordination and quality reporting."

About CitiusTech

CitiusTech is a specialist provider of healthcare technology services and solutions to healthcare IT vendors, providers, ACOs,and health plans. CitiusTech offers a wide range of healthcare technology services including healthcare software development, healthcare interoperability, Meaningful Use compliance, BI /analytics, care management and consumer health.

CitiusTech's BI-Clinical platform is s market leader in healthcare BI/ analytics. CitiusTech brings strong healthcare expertise across technologies, applications and standards. Our ability to providethis expertise, together with world-class service quality and aglobal resource base, enables us to deliver best-in- class solutions and an unmatched cost advantage to healthcare clients worldwide.

For further information:
CitiusTech Inc.
Sujay Pal
Manager - Corporate Marketing

SOURCE CitiusTech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
2. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
3. Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
4. Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol
5. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
6. Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
7. China Sky One Medical, Inc. Completes Acquisition of Peng Lai Jin Chuang Company
8. Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
9. Roche completes acquisition of ARIUS
10. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
11. Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908
Post Your Comments:
(Date:11/30/2015)... 2015  Northwest Biotherapeutics (NASDAQ: NWBO ) ("NW ... therapies for solid tumor cancers, announced today that the ... and the Company welcomes Neil Woodford,s call ... anonymous internet report on NW Bio.  The Company,s Board ... Powers stated, "We agree with Mr. Woodford that, ...
(Date:11/30/2015)... PETACH TIKVAH, Israel , Nov. 30, 2015 ... ), a leading developer of adult stem cell technologies for ... Therapeutics Ltd., has been awarded an additional grant of approximately ... Chief Scientist (OCS). This grant, the second this year, brings ... to approximately $1.8 million (approximately NIS7 million).  ...
(Date:11/27/2015)... Nov. 27, 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: ... that it has closed the sale of its global ... (GBT- NYSE Euronext) in a transaction valued at approximately ... facilities and a total of approximately 1,000 employees spread ... St. Louis area. This entire workforce ...
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is ... cancer biomarkers market with pharmaceutical companies and ... companion diagnostic tests. . ... Complete report on global cancer biomarkers ...
Breaking Biology Technology:
(Date:11/17/2015)... PARIS , November 17, 2015 ... November 2015.   --> Paris from ... --> DERMALOG, the biometrics innovation leader, has invented the ... and fingerprints on the same scanning surface. Until now two ... fingerprints. Now one scanner can capture both on the same ...
(Date:11/17/2015)... EASTON, Mass. , Nov. 17, 2015 ... a leader in the development and sale of broadly ... the worldwide life sciences industry, today announced it has ... of its $5 million Private Placement (the "Offering"), increasing ... to $4,025,000.  One or more additional closings are expected ...
(Date:11/12/2015)... Mass. , Nov. 12, 2015  Arxspan ... Institute of MIT and Harvard for use of ... discovery information management tools. The partnership will support ... both biological and chemical research information internally and ... will be used for managing the Institute,s electronic ...
Breaking Biology News(10 mins):